Octreotide Ameliorates Glucose Intolerance Following Acute Experimental Pancreatitis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Digestive Diseases and Sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1018861112495PMID 9508525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histochemical and ultrastructural characteristics of tubular complexes in human acute pancreatitis

  2005cited by this paper
• Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.

  1996cited by this paper
• Effects of delayed administration of octreotide in acute experimental pancreatitis.

  1996cited by this paper
• Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages.

  1994cited by this paper
• Potential role of somatostatin and octreotide in the management of acute pancreatitis.

  1994cited by this paper
• Insulin Sensitivity Test Using a Somatostatin Analogue, Octreotide (Sandostatin®)

  1994cited by this paper
• A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development

  1993cited by this paper
• A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis.

  1992cited by this paper
• Involvement of Tubular Complexes in Pancreatic Regeneration After Acute Necrohemorrhagic Pancreatitis

  1991cited by this paper
• Adverse Effect of Therapeutic Vasoconstrictors in Experimental Acute Pancreatitis

  1991cited by this paper
• Pancreatic regeneration after partial pancreatectomy.

  1991cited by this paper
• Relationship between glucose tolerance and quantitative changes of islet cells in chronic obstructive pancreatitis due to pancreatoduodenal cancer.

  1991cited by this paper
• A Somatostatin Analogue is Protective Against Retrograde Bile Salt‐Induced Pancreatitis in the Rat

  1991cited by this paper
• The therapeutic role of octreotide in the management of surgical disorders.

  1991cited by this paper
• Acute pancreatitis and octreotide.

  1991cited by this paper
• Essential Role of Cholecystokinin in Pancreatic Regeneration After 60% Distal Resection in Rats

  1991cited by this paper
• Does somatostatin analogue prevent experimental acute pancreatitis?

  1990cited by this paper
• The use of somatostatin in acute pancreatitis--results of a multicenter trial.

  1990cited by this paper
• All aboard for octreotide.

  1990cited by this paper
• Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial.

  1989cited by this paper
• Effect of octreotide acetate on pancreatic exocrine function.

  1989cited by this paper
• The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus.

  1989cited by this paper
• Effect of SMS201-995 (a long-acting somatostatin analog) on bile-induced acute hemorrhagic pancreatitis in the dog.

  1989cited by this paper
• The pathogenesis of acute pancreatitis

  1988cited by this paper
• Pathogenesis of acute pancreatitis.

  1988cited by this paper
• Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.

  1988cited by this paper
• Pancreatic growth after partial resection of normal and enlarged pancreas in rats fed soya flour.

  1988cited by this paper
• The effect of somatostatin analogue (SMS 201-995) on pancreatic blood flow.

  1988cited by this paper
• Discordance of Exocrine and Endocrine Growth After 90% Pancreatectomy in Rats

  1988cited by this paper
• Acute pancreatitis in rats: a 31P nuclear magnetic resonance study.

  1987cited by this paper
• Effects of somatostatin on acute canine experimental pancreatitits

  1987cited by this paper
• Treatment of acute pancreatitis: Comparison of animal and human studies

  1987cited by this paper
• Somatostatin in the Treatment of Acute Pancreatitis

  1987cited by this paper
• EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN

  1986cited by this paper
• Cytoprotective properties of somatostatins.

  1986cited by this paper
• Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice.

  1985cited by this paper
• Workshop on experimental pancreatitis

  1985cited by this paper
• The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models.

  1985cited by this paper
• Effects of somatostatin and a long‐acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat

  1985cited by this paper
• Somatostatin (second of two parts).

  1983cited by this paper
• Somatostatin.

  1983cited by this paper
• Cytoprotection-organoprotection by somatostatin: gastric and hepatic lesions

  1982cited by this paper
• Origin of tubular complexes in human chronic pancreatitis.

  1982cited by this paper
• Pathological anatomy and pathogenesis of acute pancreatitis

  1981cited by this paper
• Origin of Hodgkin's and Reed-Sternberg cells.

  1980cited by this paper
• Intraductal stomatostatin protects against experimentally induced pancreatitis

  1980cited by this paper
• Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes

  1980cited by this paper
• Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes.

  1980cited by this paper
• Treatment of acute pancreatitis with somatostatin.

  1980cited by this paper
• Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog.

  1979cited by this paper
• Somatostatin therapy of acute experimental pancreatitis.

  1977cited by this paper
• Acute necrotizing pancreatitis

  1974cited by this paper

• Infliximab: protective effect to intestinal barrier function of rat with acute necrosis pancreatitis at early stage.

  2013cites this paper
• Infliximab Enhances the Therapeutic Effectiveness of Octreotide on Acute Necrotizing Pancreatitis in Rat Model

  2012cites this paper
• Optical Coherence Tomography in Inflammatory Bowel Disease: Prospective Evaluation of 35 Patients

  2008cites this paper
• Human interleukin 10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats.

  2002cites this paper
• Interkukin-10 Attenuates Proinflammatory Cytokine Production and Improves Survival in Lethal Pancreatitis

  2001cites this paper
• The effects of somatostatin and octreotide on experimental and human acute pancreatitis.

  2000cites this paper
• Continuous Intravenous Octreotide Treatment for Acute Experimental Pancreatitis

  1999cites this paper
• Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat.

  1999cites this paper